PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma

BACKGROUND: Molecular biomarkers assisting risk-group assignment and subsequent treatment stratification are urgently needed for patients with squamous cell cancer of the head and neck region (HNSCC). Aberrant methylation is a frequent event in cancer and, therefore, a promising source for potential...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Epigenetics
Autori principali: Sailer, Verena, Holmes, Emily Eva, Gevensleben, Heidrun, Goltz, Diane, Dröge, Freya, Franzen, Alina, Dietrich, Jörn, Kristiansen, Glen, Bootz, Friedrich, Schröck, Andreas, Dietrich, Dimo
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5290668/
https://ncbi.nlm.nih.gov/pubmed/28174607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-017-0317-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi